UPMC Altoona, located in downtown Altoona, Pennsylvania, is a 380-bed, non-profit, private community hospital system that contains more than 20 affiliated health care companies and functions as the regional referral center and tertiary hub of the University of Pittsburgh Medical Center.

There are 380 beds in UPMC Altoona.

During the past decade, UPMC Altoona conducted 30 clinical trials. In the 10-year time frame, 30 clinical trials started and 1 clinical trials were completed, i.e. on average, 3.3% percent of trials that started reached the finish line to date. In the past 5 years, 21 clinical trials started and 1 clinical trials were completed. i.e. 4.8% of trials that started reached the finish line.

Out of the total clinical trials conducted in "UPMC Altoona" #1 sponsor was "National Cancer Institute (NCI)" with 14 trials, followed by "NRG Oncology" with 5 trials sponsored, "Alliance for Clinical Trials in Oncology" with 4 trials sponsored, "ECOG-ACRIN Cancer Research Group" with 3 trials sponsored and "SWOG Cancer Research Network" with 3 trials sponsored. Other sponsors include -2 different institutions and companies that sponsored additional 8 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "UPMC Altoona" #1 collaborator was "National Cancer Institute (NCI)" with 14 trials as a collaborator, "NRG Oncology" with 3 trials as a collaborator, "National Institute of Neurological Disorders and Stroke (NINDS)" with 2 trials as a collaborator, "American Heart Association" with 1 trials as a collaborator and "Bristol-Myers Squibb" with 1 trials as a collaborator. Other collaborators include 3 different institutions and companies that were collaborators in the rest 13 trials.

According to Clinical.Site data, the most researched conditions in "UPMC Altoona" are "Stage IIIB Lung Cancer AJCC v8" (4 trials), "Stage IV Lung Cancer AJCC v8" (4 trials), "Lung Non-Squamous Non-Small Cell Carcinoma" (3 trials), "Prostate Adenocarcinoma" (3 trials) and "Recurrent Lung Non-Small Cell Carcinoma" (3 trials). Many other conditions were trialed in "UPMC Altoona" in a lesser frequency.

Most popular intervention types in "UPMC Altoona" are "Drug" (28 trials), "Other" (17 trials), "Biological" (12 trials), "Procedure" (12 trials) and "Radiation" (12 trials). Other intervention types were less common.

The name of intervention was led by "Quality-of-Life Assessment" (12 trials), "Computed Tomography" (10 trials), "Carboplatin" (9 trials), "Cisplatin" (9 trials) and "Magnetic Resonance Imaging" (8 trials). Other intervention names were less common.

The vast majority of trials in "UPMC Altoona" are 26 trials for "All" genders, 4 trials for "Male" genders and 1 trials for "Female" genders.

Currently, there are NaN active trials in "UPMC Altoona". undefined are not yet recruiting, 20 are recruiting, 8 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 1 completed trials in UPMC Altoona, 2 suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in UPMC Altoona, 0 "Phase 1" clinical trials were conducted, 16 "Phase 2" clinical trials and 18 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 2 trials that are defined as “Not Applicable".